Skip to content

Media
Investors
Contact

<img width="295" height="60" data-src="https://www.sol-gel.com/wp-content/uploads/2023/12/sol-gel-logo-KO-text.svg" class="custom-logo lazyload" alt="Sol-Gel" decoding="async" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" style="--smush-placeholder-width: 295px; --smush-placeholder-aspect-ratio: 295/60;" /><noscript><img width="295" height="60" data-src="https://www.sol-gel.com/wp-content/uploads/2023/12/sol-gel-logo-KO-text.svg" class="custom-logo lazyload" alt="Sol-Gel" decoding="async" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" style="--smush-placeholder-width: 295px; --smush-placeholder-aspect-ratio: 295/60;" /><noscript><img width="295" height="60" src="https://www.sol-gel.com/wp-content/uploads/2023/12/sol-gel-logo-KO-text.svg" class="custom-logo" alt="Sol-Gel" decoding="async" />

Pipeline
- Overview
- SGT-610
- SGT-210
- Partnerships
Products
- TWYNEO^®
- EPSOLAY^®
Therapeutic Focus
About

<img width="295" height="60" data-src="https://www.sol-gel.com/wp-content/uploads/2023/12/sol-gel-logo-KO-text.svg" class="custom-logo lazyload" alt="Sol-Gel" decoding="async" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" style="--smush-placeholder-width: 295px; --smush-placeholder-aspect-ratio: 295/60;" /><noscript><img width="295" height="60" data-src="https://www.sol-gel.com/wp-content/uploads/2023/12/sol-gel-logo-KO-text.svg" class="custom-logo lazyload" alt="Sol-Gel" decoding="async" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" style="--smush-placeholder-width: 295px; --smush-placeholder-aspect-ratio: 295/60;" /><noscript><img width="295" height="60" src="https://www.sol-gel.com/wp-content/uploads/2023/12/sol-gel-logo-KO-text.svg" class="custom-logo" alt="Sol-Gel" decoding="async" />

<img width="295" height="60" data-src="https://www.sol-gel.com/wp-content/uploads/2023/12/sol-gel-logo-KO-text.svg" class="custom-logo lazyload" alt="Sol-Gel" decoding="async" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" style="--smush-placeholder-width: 295px; --smush-placeholder-aspect-ratio: 295/60;" /><noscript><img width="295" height="60" data-src="https://www.sol-gel.com/wp-content/uploads/2023/12/sol-gel-logo-KO-text.svg" class="custom-logo lazyload" alt="Sol-Gel" decoding="async" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" style="--smush-placeholder-width: 295px; --smush-placeholder-aspect-ratio: 295/60;" /><noscript><img width="295" height="60" src="https://www.sol-gel.com/wp-content/uploads/2023/12/sol-gel-logo-KO-text.svg" class="custom-logo" alt="Sol-Gel" decoding="async" />

Pipeline
- Overview
- SGT-610
- SGT-210
- Partnerships
Products
- TWYNEO^®
- EPSOLAY^®
Therapeutic Focus
About

<img width="295" height="60" data-src="https://www.sol-gel.com/wp-content/uploads/2023/12/sol-gel-logo-KO-text.svg" class="custom-logo lazyload" alt="Sol-Gel" decoding="async" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" style="--smush-placeholder-width: 295px; --smush-placeholder-aspect-ratio: 295/60;" /><noscript><img width="295" height="60" data-src="https://www.sol-gel.com/wp-content/uploads/2023/12/sol-gel-logo-KO-text.svg" class="custom-logo lazyload" alt="Sol-Gel" decoding="async" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" style="--smush-placeholder-width: 295px; --smush-placeholder-aspect-ratio: 295/60;" /><noscript><img width="295" height="60" src="https://www.sol-gel.com/wp-content/uploads/2023/12/sol-gel-logo-KO-text.svg" class="custom-logo" alt="Sol-Gel" decoding="async" />

Contact

Interested in learning more about Sol-Gel? We’d love to hear from you.

Name *

Email *

Subject *

Message *

Please do not fill in this field.

Sol-Gel Technologies Ltd.

Golda Meir 7, Ness Ziona, Israel

Corporate Contact

[email protected]
+972-8-9313433

Pipeline
- Overview
- SGT-610
- SGT-210
- Partnerships
Products
- TWYNEO^®
- EPSOLAY^®
Therapeutic Focus
About
Media
Investors
Contact

Copyright © 2024 Sol-Gel Technologies Ltd. All Rights Reserved.

Pipeline
- Overview
- SGT-610
- SGT-210
- Partnerships
Products
- TWYNEO^®
- EPSOLAY^®
Therapeutic Focus
About
Media
Investors
Contact

SCIENCE

Pipeline
Products
Therapeutic Focus
Gorlin Syndrome
Pachyonychia Congenita
Partnerships

Company

About
Management
Board of Directors
Media
Contact
Careers

Investors

Overview
Press Releases
Events & Presentations
Corporate Governance
Financial Information
Stock Information

Copyright © 2024 Sol-Gel Technologies Ltd. All Rights Reserved.

Scroll to Top